AngioDynamics, Inc.
NASDAQ:ANGO
6.68 (USD) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 303.914 | 338.752 | 316.219 | 291.01 | 264.157 | 359.484 | 344.285 | 349.643 | 353.69 | 356.974 | 354.455 | 342.026 | 221.787 | 215.957 | 216.035 | 195.054 | 166.5 | 112.227 | 78.451 | 60.289 | 49.055 | 38.434 | 30.89 | 23.39 |
| Cost of Revenue
| 162.264 | 164.506 | 150.487 | 134.222 | 113.885 | 167.612 | 167.41 | 173.474 | 179.721 | 180.085 | 174.594 | 173.037 | 95.829 | 90.111 | 89.066 | 74.989 | 63.913 | 46.06 | 32.93 | 26.912 | 23.254 | 18.572 | 15.333 | 12.418 |
| Gross Profit
| 141.65 | 174.246 | 165.732 | 156.788 | 150.272 | 191.872 | 176.875 | 176.169 | 173.969 | 176.889 | 179.861 | 168.989 | 125.958 | 125.846 | 126.969 | 120.065 | 102.587 | 66.167 | 45.521 | 33.377 | 25.801 | 19.862 | 15.557 | 10.972 |
| Gross Profit Ratio
| 0.466 | 0.514 | 0.524 | 0.539 | 0.569 | 0.534 | 0.514 | 0.504 | 0.492 | 0.496 | 0.507 | 0.494 | 0.568 | 0.583 | 0.588 | 0.616 | 0.616 | 0.59 | 0.58 | 0.554 | 0.526 | 0.517 | 0.504 | 0.469 |
| Reseach & Development Expenses
| 31.512 | 29.883 | 30.739 | 36.39 | 29.682 | 29.435 | 25.459 | 25.269 | 25.126 | 26.931 | 27.51 | 26.319 | 20.511 | 21.372 | 19.275 | 17.914 | 14.424 | 20.555 | 5.869 | 4.57 | 3.551 | 2.509 | 1.951 | 1.426 |
| General & Administrative Expenses
| 41.164 | 40.003 | 38.451 | 35.918 | 37.872 | 35.173 | 31.265 | 31.406 | 29.206 | 29.871 | 26.035 | 26.127 | 18.334 | 17.828 | 16.437 | 20.136 | 15.425 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 102.818 | 104.249 | 95.301 | 81.306 | 78.634 | 80.958 | 77.276 | 78.819 | 84.911 | 80.623 | 83.2 | 76.121 | 64.505 | 58.123 | 60.923 | 56.785 | 46.047 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 142.909 | 144.252 | 133.752 | 117.224 | 116.506 | 116.131 | 108.541 | 110.225 | 114.117 | 110.494 | 109.235 | 102.248 | 82.839 | 75.951 | 77.36 | 76.921 | 61.472 | 56.837 | 29.346 | 21.08 | 17.127 | 14.115 | 11.218 | 0 |
| Other Expenses
| -1.073 | 18.79 | 19.458 | 18.136 | 18.121 | 19.772 | -0.031 | -3.12 | -5.008 | -7.005 | -7.068 | -7.739 | 9.406 | 16.416 | 9.463 | 9.126 | 10.455 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 175.494 | 192.925 | 183.949 | 171.75 | 164.309 | 165.338 | 150.635 | 150.953 | 159.777 | 159.479 | 157.371 | 146.698 | 112.756 | 106.557 | 106.098 | 103.961 | 86.351 | 77.392 | 35.215 | 25.65 | 20.678 | 16.624 | 13.169 | 1.426 |
| Operating Income
| -33.844 | -19.233 | -19.007 | -14.87 | -14.167 | 21.435 | 10.558 | 14.967 | 0.653 | -0.994 | 13.448 | 7.094 | -2.962 | 12.107 | 20.871 | 16.104 | 16.236 | -11.225 | 10.306 | 7.727 | 5.123 | 3.238 | 2.388 | -0.29 |
| Operating Income Ratio
| -0.111 | -0.057 | -0.06 | -0.051 | -0.054 | 0.06 | 0.031 | 0.043 | 0.002 | -0.003 | 0.038 | 0.021 | -0.013 | 0.056 | 0.097 | 0.083 | 0.098 | -0.1 | 0.131 | 0.128 | 0.104 | 0.084 | 0.077 | -0.012 |
| Total Other Income Expenses Net
| -157.794 | -35.204 | -10.942 | -21.182 | -152.968 | -13.45 | -15.713 | -13.369 | -18.547 | -25.409 | -16.11 | -22.936 | -18.484 | -8.447 | -1.252 | -1.78 | -4.343 | 0.314 | 0.162 | -0.264 | -0.742 | -0.983 | -0.818 | -0.88 |
| Income Before Tax
| -191.638 | -54.437 | -29.949 | -36.052 | -167.135 | 59.469 | 7.465 | 11.847 | -4.355 | -7.999 | 6.38 | -0.645 | -5.282 | 10.842 | 19.619 | 15.152 | 17.328 | -7.172 | 11.122 | 7.618 | 4.381 | 2.255 | 1.57 | -1.17 |
| Income Before Tax Ratio
| -0.631 | -0.161 | -0.095 | -0.124 | -0.633 | 0.165 | 0.022 | 0.034 | -0.012 | -0.022 | 0.018 | -0.002 | -0.024 | 0.05 | 0.091 | 0.078 | 0.104 | -0.064 | 0.142 | 0.126 | 0.089 | 0.059 | 0.051 | -0.05 |
| Income Tax Expense
| -7.289 | -1.995 | -3.402 | -4.504 | -1.348 | -1.871 | -8.87 | 4.839 | 40.096 | -4.731 | 3.292 | -0.031 | -0.188 | 2.616 | 7.307 | 5.22 | 6.439 | 1.955 | 4.256 | 3.069 | 1.238 | 1.069 | 0.561 | -1.513 |
| Net Income
| -184.349 | -52.442 | -26.547 | -31.548 | -165.787 | 61.34 | 16.335 | 7.008 | -44.451 | -3.268 | 3.088 | -0.614 | -5.094 | 8.226 | 12.312 | 9.932 | 10.889 | -9.127 | 6.866 | 4.548 | 3.143 | 1.186 | 1.009 | 0.343 |
| Net Income Ratio
| -0.607 | -0.155 | -0.084 | -0.108 | -0.628 | 0.171 | 0.047 | 0.02 | -0.126 | -0.009 | 0.009 | -0.002 | -0.023 | 0.038 | 0.057 | 0.051 | 0.065 | -0.081 | 0.088 | 0.075 | 0.064 | 0.031 | 0.033 | 0.015 |
| EPS
| -4.59 | -1.33 | -0.68 | -0.82 | -4.37 | 1.64 | 0.44 | 0.19 | -1.23 | -0.092 | 0.09 | -0.018 | -0.2 | 0.33 | 0.5 | 0.41 | 0.45 | -0.49 | 0.55 | 0.39 | 0.34 | 0.13 | 0.11 | 0.04 |
| EPS Diluted
| -4.59 | -1.33 | -0.68 | -0.82 | -4.37 | 1.64 | 0.44 | 0.19 | -1.23 | -0.092 | 0.09 | -0.018 | -0.2 | 0.33 | 0.5 | 0.41 | 0.45 | -0.49 | 0.53 | 0.37 | 0.32 | 0.13 | 0.11 | 0.04 |
| EBITDA
| -6.096 | 11.64 | 10.342 | 11.046 | 9.638 | 98.799 | 49.372 | 60.276 | 56.11 | 66.306 | 56.582 | 66.557 | 44.73 | 40.315 | 34.582 | 29.718 | 29.448 | -8.13 | 11.226 | 8.762 | 5.804 | 3.895 | 2.957 | 9.546 |
| EBITDA Ratio
| -0.02 | 0.034 | 0.033 | 0.038 | 0.036 | 0.275 | 0.143 | 0.172 | 0.159 | 0.186 | 0.16 | 0.195 | 0.202 | 0.187 | 0.16 | 0.152 | 0.177 | -0.072 | 0.143 | 0.145 | 0.118 | 0.101 | 0.096 | 0.408 |